Status:
UNKNOWN
Long Term Outcomes of Venous Thromboembolism
Lead Sponsor:
Ostfold Hospital Trust
Conditions:
Post Thrombotic Syndrome
Chronic Thromboembolic Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This prospective observational follow-up study is designed to assess the long-term outcomes after Venous thromboembolism (VTE) and to assess the effect of the new oral anticoagulant (NOAC) rivaroxaban...
Detailed Description
This prospective observational follow-up study is designed to assess the long-term outcomes after VTE and to assess the effect of NOAC (rivaroxaban) on the prevalence of PTS. All patients diagnosed an...
Eligibility Criteria
Inclusion
- Patients with objectively verified first time DVT diagnosed after 01.01.11 for study A, OR objectively verified DVT and/or PE dignosed after 01.04.14 for study B.
- 18 years of age
- Signed informed written consent
Exclusion
- Patients who refuse to consent
- Patients who have been treated with other anticoagulants than thoose included in the study
- Patients who can not participate due to logistic reasons
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT02268630
Start Date
January 1 2014
End Date
October 1 2023
Last Update
February 16 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Lørenskog, Akershus, Norway, 1478
2
Ullevål University Hospital
Oslo, Oslo County, Norway, 0450
3
Ostfold Hospital Trust
Fredrikstad, Østfold fylke, Norway, 1606